tripelennamine has been researched along with Contact Dermatitis in 3 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BARRETT, RJ | 1 |
STRAUSS, RE | 1 |
BRUCK, CR | 1 |
WHITNEY, LH | 1 |
3 other studies available for tripelennamine and Contact Dermatitis
Article | Year |
---|---|
Zirconium and pyribenzamine in treatment of ivy poisoning.
Topics: Dermatitis; Dermatitis, Contact; Tripelennamine; Zirconium | 1952 |
Zirconiumpyribenzamine cream for the prophylaxis of rhus dermatitis.
Topics: Dermatitis; Dermatitis, Contact; Dermatitis, Toxicodendron; Humans; Tripelennamine; Zirconium | 1953 |
A skin cream for the prevention and treatment of ivy dermatitis.
Topics: Biomedical Research; Dermatitis; Dermatitis, Contact; Skin Cream; Tripelennamine; Zirconium | 1955 |